January 16, 2013 — Lantheus Medical Imaging Inc. has added a low-enriched uranium (LEU) TechneLite (technetium Tc 99m ...
January 10, 2013 — Bayer HealthCare announced that the company has submitted a new drug application (NDA) to the U.S ...
December 26 , 2012 — Congress last week affirmed its dedication to securing a sustainable, domestic supply of molybdenum ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
November 20, 2012 — Lantheus Medical Imaging Inc. and two medical isotope producers have agreed to work together to help ...
November 2, 2012 – Molecular imaging with positron emission tomography (PET) has enabled scientists for the first time ...
October 25, 2012 — Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
October 16, 2012 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued an updated practice ...
September 14, 2012 — IBA Molecular North America Inc., a manufacturer and distributor of PET imaging tracers, has ...
September 14, 2012 — The U.S. Food and Drug Administration (FDA) has approved the production and use of Choline C-11 ...
September 12, 2012 – Positron Corp. announced that Jubilant DraxImage Inc., a Jubilant Life Sciences company, and ...
Like an eyewitness to a freight train bearing down on a rocket fuel truck at a railroad crossing, I couldn’t avoid ...
August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file ...
August 21, 2012 — Siemens Healthcare announced that its syngo.PET Amyloid Plaque proprietary software has received ...
August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical ...
August 7, 2012 — RadNet Inc. announced it will offer Amyvid, a radioactive tracer used in positron emission tomography ...
August 7, 2012 — Navidea Biopharmaceuticals Inc., a company focused on precision diagnostic radiopharmaceuticals ...
August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging ...
August 2, 2012 — When combined with standard diagnostic tests, functional imaging procedures have been shown to reduce ...
July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds ...
July 24, 2012 — Navidea Biopharmaceuticals Inc., a specialty pharmaceutical company focused on precision diagnostic ...